MicThera harnesses microbes to discover breakthrough therapeutics, leveraging microbial bioactive molecules -synthetically produced- to overcome therapy resistance. Our discovery platform unlocks microbial-inspired therapeutics to develop innovative treatments.

Products, services, technology

Our pipeline targets cancer and antimicrobial resistance by harnessing microbial-inspired therapeutics. In addition, we have developed an innovative platform combining AI and drug screening to discover the next generation of microbial-inspired therapeutic compounds.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2023
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in